Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Oxaprozin MeSH Descriptor Data 2025


MeSH Heading
Oxaprozin
Tree Number(s)
D02.241.081.751.634
D03.383.129.462.590
Unique ID
D000077431
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077431
Scope Note
An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
Entry Term(s)
4,5-Diphenyl-2-oxazolepropionic Acid
Apo-Oxaprozin
Danoprox
Daypro
Dayrun
Rhoxal-oxaprozin
Wy-21,743
Pharm Action
Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase Inhibitors
Registry Numbers
MHJ80W9LRB
0
Related Numbers
21256-18-8
Public MeSH Note
2019; OXAPROZIN was indexed under PROPIONATES 1983-2018; under OXAZOLES 1980-1982; under PROPIONIC ACIDS 1979-1980; and under PROPIONATES 1975-1979
History Note
2019 (1975)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/04/10
Oxaprozin Preferred
Wy-21,743 Narrower
Daypro Narrower
Danoprox Narrower
Dayrun Narrower
Rhoxal-oxaprozin Narrower
Apo-Oxaprozin Narrower
page delivered in 0.119s